Table of Content


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Material
3.2. Snippet by Cell Design
3.3. Snippet by Stent Diameter
3.4. Snippet by Application
3.5. Snippet by End-User
3.6. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Advancements in Venous Stents
4.1.2. Restraints
4.1.2.1. High Cost of the Venous Stenting
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
5.9. Technology and Trend Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Material
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
7.1.2. Market Attractiveness Index, By Material
7.2. Nitinol*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Elgiloy
7.4. Others
8. By Cell Design
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Design
8.1.2. Market Attractiveness Index, By Cell Design
8.2. Open-Cell*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Closed-Cell
8.4. Hybrid
9. By Stent Diameter
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Stent Diameter
9.1.2. Market Attractiveness Index, By Stent Diameter
9.2. 10 mm*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. 12 mm
9.4. 14 mm
9.5. 16 mm
9.6. 18 mm
9.7. 20 mm
9.8. 22 mm
9.9. 24 mm
9.10. Others
10. By Application
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Iliocaval Venous Obstruction*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Post-Thrombotic Syndrome
10.4. Acute Iliofemoral Deep Vein Thrombosis
10.5. Peripheral Artery Disease
10.6. Symptomatic Venous Outflow Obstruction
10.7. Others
11. By End-User
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.1.2. Market Attractiveness Index, By End-User
11.2. Hospitals*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Specialty Clinics
11.4. Academic and Research Institutes
11.5. Others
12. By Region
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Design
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Stent Diameter
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Design
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Stent Diameter
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. UK
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Design
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Stent Diameter
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Design
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Stent Diameter
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Design
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Stent Diameter
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. Company Profiles
14.1. Cook Medical*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. W. L. Gore & Associates, Inc.
14.3. Boston Scientific Corporation
14.4. Becton, Dickinson and Company
14.5. Medtronic plc
14.6. Vesper Medical, Inc.
14.7. optimed Medizinische Instrumente GmbH
14.8. Koninklijke Philips N.V.
14.9. Bentley InnoMed GmbH
14.10. Shanghai MicroPort Medical (Group) Co.?Ltd.
LIST NOT EXHAUSTIVE
15. Appendix
15.1. About Us and Services
15.2. Contact Us